Have you or your loved ones been diagnosed with advanced malignant solid neoplasm?

You may be eligible to participate in a advanced malignant solid neoplasm clinical trial.

Have you or your loved ones been diagnosed with advanced malignant solid neoplasm? You may be eligible to participate in a advanced malignant solid neoplasm clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Advanced Malignant Solid Neoplasm Clinical Trial in Houston TX
NCT01738139 | Phase 1 | Interventional

Have you or your loved ones been diagnosed with advanced malignant solid neoplasm?

You may be eligible to participate in a advanced malignant solid neoplasm clinical trial.

Have you or your loved ones been diagnosed with advanced malignant solid neoplasm? You may be eligible to participate in a advanced malignant solid neoplasm clinical trial.

Recruiting

Male & Female

15 Years +

This study is looking to recruit 96 Participants

This phase I trial studies the side effects and best dose of ipilimumab and imatinib mesylate in treating patients with solid tumors that have spread to other places in the body or cannot be removed by surgery. Immunotherapy with monoclonal antibodies, such as ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Imatinib mesylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving ipilimumab and imatinib mesylate may work better in treating patients with solid tumors.